Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3

UK CHIC Study Group, Kholoud Porter, Sarah Walker, Teresa Hill, Jane Anderson, Clifford Leen, Margaret Johnson, Brian Gazzard, John Walsh, Martin Fisher, Chloe Orkin, Achim Schwenk, Richard Gilson, Philippa Easterbrook, Valerie Delpech, Caroline A Sabin

Research output: Contribution to journalArticlepeer-review

Abstract

Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART) initiation before reaching a CD4 count of 200 cells/mm3, many people in resource-rich settings, and a substantial proportion in resource-limited settings, present at levels
Original languageEnglish
Pages (from-to)202-5
Number of pages4
JournalJournal of Acquired Immune Deficiency Syndromes
Volume47
Issue number2
DOIs
Publication statusPublished - 1 Feb 2008

Keywords

  • Adult
  • Age Factors
  • Anti-HIV Agents
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Female
  • Great Britain
  • HIV Infections
  • Humans
  • Male
  • Sex Factors
  • Treatment Outcome
  • Viral Load

Fingerprint

Dive into the research topics of 'Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3'. Together they form a unique fingerprint.

Cite this